Hospira.comAbout HospiraNews & MediaIn the Community
Home
Australia

Q2 Plus Monitoring System:

  • Provide rapid response to changes in cardiac output
  • Eliminate the need for bolus cardiac output injections
  • Exclusive 3-wavelength technology provides reliable SvO2 measurements without need for laboratory updates of hemoglobin or hematocrit
  • Quality Signal Indicator (QSI) communicates the strength of the CCO output signal
  • User selected signal processing modes provide flexibility